Kingfisher Capital LLC Eli Lilly & CO Transaction History

Kingfisher Capital LLC

$428 Million
Q2 2024

A detailed history of Kingfisher Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kingfisher Capital LLC holds 11,018 shares of LLY stock, worth $9.77 Million. This represents 2.33% of its overall portfolio holdings.

Number of Shares

11,018

Previous 11,034 0.15%

Holding current value

$9.77 Million

Previous $8.58 Million 16.2%

% of portfolio

2.33%

Previous 2.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $11,597 - $14,544	-16 Reduced 0.15%	11,018 $9.98 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $12,436 - $16,637	-21 Reduced 0.19%	11,034 $8.58 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.28 Million - $1.51 Million	2,440 Added 28.32%	11,055 $6.44 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $18,692 - $25,769	43 Added 0.5%	8,615 $4.63 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $223,421 - $298,740	-637 Reduced 6.92%	8,572 $4.02 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $1.94 Million - $2.28 Million	6,242 Added 210.38%	9,209 $3.16 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $4,501 - $5,245	-14 Reduced 0.47%	2,967 $1.09 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $8,361 - $9,818	30 Added 1.02%	2,981 $966,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $5,867 - $7,291	25 Added 0.85%	2,951 $845,000
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $22,160 - $27,270	100 Added 3.54%	2,926 $676,000
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $46,040 - $59,552	-255 Reduced 8.28%	2,826 $649,000
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $37,136 - $48,074	226 Added 7.92%	3,081 $576,000
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $7,175 - $9,494	55 Added 1.96%	2,855 $482,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $35,158 - $39,388	-332 Reduced 10.6%	2,800 $324,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $74,784 - $93,467	-871 Reduced 21.76%	3,132 $336,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $20,514 - $23,544	271 Added 7.26%	4,003 $342,000
Q1 2018 May 16, 2018	BUY	$74.21 - $87.6 $44,525 - $52,560	600 Added 19.16%	3,732 $289,000
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $245 - $263	-3 Reduced 0.1%	3,132 $265,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $25,818 - $28,655	335 Added 11.96%	3,135 $268,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,800	2,800 $230,000

Others Institutions Holding LLY

# of Institutions

3,870

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingfisher Capital LLC with notifications on news.

Account

Kingfisher Capital LLC Eli Lilly & CO Transaction History